Regulation of immunity to respiratory syncytial virus by dendritic cells, toll-like receptors, and notch

Viral Immunology

Volumn 21, Issue 2, 2008, Pages 115-122

  Lukacs, Nicholas W ^a   Smit, Joost J ^a   Schaller, Matthew A ^a   Lindell, Dennis M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HELPER FACTOR; INTERLEUKIN 12; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NUCLEIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IMMUNITY;

DENDRITIC CELLS; HUMANS; RECEPTORS, NOTCH; RESPIRATORY SYNCYTIAL VIRUSES; TOLL-LIKE RECEPTORS;

RESPIRATORY SYNCYTIAL VIRUS;

EID: 45749111409     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2007.0110     Document Type: Conference Paper

References (88)

1. Busse WW, Gern JE, and Dick EC: The role of respiratory viruses in asthma. Ciba Found Symp 1997;206:208.
2. Stempel DA, and Boucher RC: Respiratory infection and airway reactivity. Med Clin North Am 1981;65:1045.
3. Hogg JC: Childhood viral infection and the pathogenesis of asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 1999;160:S26.
4. Holtzman MJ, Morton JD, Shornick LP, et al.: Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev 2002;82:19.
5. Nicholson KG, Kent J, and Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982.
6. Zhao J, Takamura M, Yamaoka A, Odajima Y, and Iikura Y: Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. Pediatr Allergy Immunol 2002;13:47.
7. Simpson JL, Moric I, Wark PA, Johnston SL, and Gibson PG: Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic techniques. J Clin Virol 2003;26:339.
8. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, and Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179.
9. Williams BR: Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc Trans 1997;25:509.
10. Carlson CB, Stephens OM, and Beal PA: Recognition of double-stranded RNA by proteins and small molecules. Biopolymers 2003;70:86.
11. Yoneyama M, Kikuchi M, Natsukawa T, et al.: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730.
12. Kurt-Jones EA, Popova L, Kwinn L, et al.: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000;1:398.
13. van der Sluijs KF, van Elden L, Nijhuis M, et al.: Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus. Immunol Lett 2003; 89:201.
14. Ehl S, Bischoff R, Ostler T, Vallbracht S, Schulte-Monting J, Poltorak A, and Freudenberg M: The role of toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 2004;34:1146.
15. Faisca P, Tran Anh DB, Thomas A, and Desmecht D: Suppression of pattern-recognition receptor TLR4 sensing does not alter lung responses to pneumovirus infection. Microbes Infect 2006;8:621.
16. Tal G, Mandelberg A, Dalal I, et al.: Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004;189:2057.
17. Mandelberg A, Tal G, Naugolny L, et al.: Lipopolysaccharide hyporesponsiveness as a risk factor for intensive care unit hospitalization in infants with respiratory syncytial virus bronchiolitis. Clin Exp Immunol 2006;144:48.
18. Puthothu B, Forster J, Heinzmann A, and Krueger M: TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis Markers 2006;22:303.
19. Rallabhandi P, Bell J, Boukhvalova MS, et al.: Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006;177:322.
20. Awomoyi AA, Rallabhandi P, Pollin TI, et al.: Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 2007;179:3171.
21. Paulus SC, Hirschfeld AF, Victor RE, Brunstein J, Thomas E, and Turvey SE: Common human toll-like receptor 4 polymorphisms - role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin Immunol 2007;123:252.
22. Tulic MK, Hurrelbrink RJ, Prele CM, et al.: TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol 2007;179:132.
23. Colonna M: TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol 2007;37:306.
24. Steinman RM, and Hemmi H: Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006;311:17.
25. Kaisho T, and Akira S: Regulation of dendritic cell function through toll-like receptors. Curr Mol Med 2003;3:373.
26. Barchet W, Cella M, and Colonna M: Plasmacytoid dendritic cells - virus experts of innate immunity. Semin Immunol 2005;17:253.
27. Ito T, Wang YH, and Liu YJ: Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol 2005;26:221.
28. Fitzgerald-Bocarsly P: Natural interferon-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques 2002;Suppl:16.
29. Smit JJ, Rudd BD, and Lukacs NW: Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med 2006; 203:1153.
30. Wang H, Peters N, and Schwarze J: Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol 2006;177:6263.
31. Yoneyama H, Matsuno K, Toda E, et al.: Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005;202:425.
32. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, and Trinchieri G: Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003;171:6466.
33. Rudd BD, Schaller MA, Smit JJ, et al.: MyD88-mediated instructive signals in dendritic cells regulate pulmonary immune responses during respiratory virus infection. J Immunol 2007;178:5820.
34. Banchereau J, Paczesny S, Blanco P, Bennett L, Pascual V, Fay J, and Palucka AK: Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann NY Acad Sci 2003;987:180.
35. Wilson HL, and O'Neill HC: Murine dendritic cell development: difficulties associated with subset analysis. Immunol Cell Biol 2003;81:239.
36. de Jong EC, Smits HH, and Kapsenberg ML: Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 2005;26:289.
37. Liu YJ, Soumelis V, Watanabe N, et al.: TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007;25:193.
38. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R, and Liu YJ: Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003;197:1059.
39. Soumelis V, Reche PA, Kanzler H, et al.: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673.
40. Zhou B, Comeau MR, De Smedt T, et al.: Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005;6:1047.
41. Ying S, O'Connor B, Ratoff J, et al.: Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005;174:8183.
42. Srinivasakumar N, Ogra PL, and Flanagan TD: Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol 1991;65:4063.
43. Kolokoltsov AA, Deniger D, Fleming EH, Roberts NJ Jr., Karpilow JM, and Davey RA: Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol 2007;81:7786.
44. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, and Brasier AR: Retinoic acid-inducible gene I mediates early antiviral response and toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 2007;81:1401.
45. Iwasaki A: Role of autophagy in innate viral recognition. Autophagy 2007;3:354.
46. Lee HK, Lund JM, Ramanathan B, Mizushima N, and Iwasaki A: Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007;315:1398.
47. Swanson MS: Autophagy: eating for good health. J Immunol 2006;177:4945.
48. Graham BS, Bunton LA, Wright PF, and Karzon DT: Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991;88:1026.
49. Openshaw PJ, Anderson K, Wertz GW, and Askonas BA: The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection. J Virol 1990;64:1683.
50. Openshaw PJ, Clarke SL, and Record FM: Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol 1992;4:493.
51. Cherrie AH, Anderson K, Wertz GW, and Openshaw PJ: Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J Virol 1992;66:2102.
52. Alwan WH, and Openshaw PJ: Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 1993;11:431.
53. Graham BS: Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Am J Respir Crit Care Med 1995;152:S63.
54. Crowe JE Jr.: Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine 1998;16:1423.
55. Dudas RA, and Karron RA: Respiratory syncytial virus vaccines. Clin Microbiol Rev 1998;11:430.
56. Chang J, and Braciale TJ: Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 2002;8:54.
57. Chang J, Srikiatkhachorn A, and Braciale TJ Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J Immunol 2001;167:4254.
58. Hussell T, Baldwin CJ, O'Garra A, and Openshaw PJ: CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 1997;27:3341.
59. de Graaff PM, de Jong EC, van Capel TM, et al.: Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J Immunol 2005;175:5904.
60. Lukacs NW, Tekkanat KK, Berlin A, et al.: Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001;167:1060.
61. Tekkanat KK, Maassab HF, Cho DS, et al.: IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol 2001;166:3542.
62. Lukacs NW, Moore ML, Rudd BD, et al.: Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol 2006;169:977.
63. Puthothu B, Krueger M, Forster J, and Heinzmann A: Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 2006;193:438.
64. Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, and Bont L: IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol 2007;119:1086.
65. You D, Becnel D, Wang K, Ripple M, Daly M, and Cormier SA: Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 2006;7:107.
66. Bont L, Kavelaars A, Heijnen CJ, van Vught AJ, and Kimpen JL: Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J Infect Dis 2000;181:1772.
67. Blanco-Quiros A, Gonzalez H, Arranz E, and Lapena S. Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis. Pediatr Pulmonol 1999;28:175.
68. Su SB, Silver PB, Grajewski RS, Agarwal RK, Tang J, Chan CC, and Caspi RR: Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol 2005;175:6303.
69. Dallman MJ, Smith E, Benson RA, and Lamb JR: Notch: control of lymphocyte differentiation in the periphery. Curr Opin Immunol 2005;17:259.
70. McKenzie GJ, Young LL, Briend E, Lamb JR, Dallman MJ, and Champion BR: Notch signalling in the regulation of peripheral T-cell function. Semin Cell Dev Biol 2003; 14:127.
71. Maillard I, Adler SH, and Pear WS: Notch and the immune system. Immunity 2003;19:781.
72. Dallman MJ, Champion B, and Lamb JR: Notch signalling in the peripheral immune system. Novartis Found Symp 2003;252:268.
73. Hoyne GF, Dallman MJ, Champion BR, and Lamb JR: Notch signalling in the regulation of peripheral immunity. Immunol Rev 2001;182:215.
74. Maillard I, Tu L, Sambandam A, et al.: The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor. J Exp Med 2006;203:2239.
75. Nam Y, Weng AP, Aster JC, and Blacklow SC: Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex. J Biol Chem 2003;278:21232.
76. Wu L, Sun T, Kobayashi K, Gao P, and Griffin JD: Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol 2002;22:7688.
77. Schmitt TM, and Zuniga-Pflucker JC: Thymus-derived signals regulate early T-cell development. Crit Rev Immunol 2005;25:141.
78. Harman BC, Jenkinson EJ, and Anderson G: Microenvironmental regulation of Notch signalling in T cell development. Semin Immunol 2003;15:91.
79. Basson MA, and Zamoyska R: The CD4/CD8 lineage decision: integration of signalling pathways. Immunol Today 2000;21:509.
80. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, and Flavell RA: Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004;117:515.
81. Rutz S, Mordmuller B, Sakano S, and Scheffold A: Notch ligands Delta-like1, Delta-like4 and Jagged1 differentially regulate activation of peripheral T helper cells. Eur J Immunol 2005;35:2443.
82. Maekawa Y, Tsukumo S, Chiba S, et al.: Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003;19:549.
83. Tu L, Fang TC, Artis D, Shestova O, Pross SE, Maillard I, and Pear WS: Notch signaling is an important regulator of type 2 immunity. J Exp Med 2005;202:1037.
84. Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, and Ray A: Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest 2006;116:996.
85. Fang TC, Yashiro-Ohtani Y, Del Bianco C, Knoblock DM, Blacklow SC, and Pear WS: Notch directly regulates gata3 expression during T helper 2 cell differentiation. Immunity 2007;27:100.
86. Amsen D, Antov A, Jankovic D, et al.: Direct regulation of gata3 expression determines the T helper differentiation potential of notch. Immunity 2007;27:89.
87. Schaller MA, Neupane R, Rudd BD, et al.: Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines. J Exp Med 2007;204:2925.
88. Skokos D, and Nussenzweig MC: CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 2007;204: 1525.